Scientists and manufacturers working on developing new vaccines and treatments, increasing the production of approved drugs, and advancing other projects to tackle COVID-19 can now access the United States Pharmacopeia-National Formulary (USP- NF) Online free for 6 months.
The USP-NF Compendium contains the most comprehensive source of drug quality standards in the world. These include analytical methods, specifications, procedures, assessments, and other guidelines for evaluating the safety and quality of a product. Companies and research groups can use these standards to market therapeutic products more effectively. They save the time and resources of having to develop processes in-house.
Compliance with USP public quality standards provides confidence that products will meet the regulatory requirements of the US Food and Drug Administration and other regulators around the world who They use USP-NF. Compliance with public quality standards also inspires the confidence needed by healthcare professionals and patients for the large-scale adoption of vaccines and treatments for COVID-19.
Resources in USP-NF can support:
- manufacturers facing drug or raw material shortages;
- research organizations and pharmaceutical companies working on analytical methods to characterize or launch a new vaccine or treatment;
- researchers, regulators, manufacturers and healthcare professionals evaluating approved drugs for new indications related to COVID-19 treatments; and
- formulators that supply or verify ingredients (excipients) for use in pharmaceutical forms.
This offer is valid only for those who are not current subscribers of the USP-NF Online platform. The trial period begins once access to the online platform is activated and ends on the last day of the sixth month. Subscribers will have the opportunity to purchase a full subscription after the free trial ends. Free trial offers must be activated before December 31, 2020.
Complete the form and verify receipt of an email within 2-3 business days with instructions on how to get started. Questions? Write to firstname.lastname@example.org.